<?xml version="1.0" encoding="UTF-8"?> <rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
> <channel><title>Medimise.com &#187; skin cancer</title> <atom:link href="http://www.medimise.com/tag/skin-cancer/feed" rel="self" type="application/rss+xml" /><link>http://www.medimise.com</link> <description>Health and Medical News</description> <lastBuildDate>Thu, 19 Jan 2012 21:20:04 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <item><title>New Skin Cancer Drug Could Cure Cancer</title><link>http://www.medimise.com/cancer/new-skin-cancer-drug-could-cure-cancer</link> <comments>http://www.medimise.com/cancer/new-skin-cancer-drug-could-cure-cancer#comments</comments> <pubDate>Wed, 23 Sep 2009 09:49:06 +0000</pubDate> <dc:creator>Medimise</dc:creator> <category><![CDATA[Cancer]]></category> <category><![CDATA[Skin]]></category> <category><![CDATA[skin cancer]]></category> <guid
isPermaLink="false">http://www.medimise.com/?p=399</guid> <description><![CDATA[TweetA new drug, called PLX4032, has been developed to block a faulty molecule present in cancer cells. It kills the tumorous cells by blocking the activity of the BRAF gene, which is believed to be the cause of the spread of skin cancer. The drug works at the molecular level, representing a seismic shift in cancer treatment. So far trials have involved just 31 people, but results have been very good. The research work is being carried out by scientists at the Memorial Sloan-Kettering Hospital in New York. The drug is only a treatment for skin cancer at the moment, which could prolong life for sufferers. It is not currently capable of curing the condition, although scientists are hopeful that this could one day lead to a cure.]]></description> <wfw:commentRss>http://www.medimise.com/cancer/new-skin-cancer-drug-could-cure-cancer/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Skin Changes, Lesions and Growths</title><link>http://www.medimise.com/cancer/types-of-skin-lesions-and-growths</link> <comments>http://www.medimise.com/cancer/types-of-skin-lesions-and-growths#comments</comments> <pubDate>Sat, 14 Feb 2009 23:07:08 +0000</pubDate> <dc:creator>Marcia</dc:creator> <category><![CDATA[Cancer]]></category> <category><![CDATA[Skin]]></category> <category><![CDATA[melanoma]]></category> <category><![CDATA[skin cancer]]></category> <category><![CDATA[skin growths]]></category> <category><![CDATA[skin lesions]]></category> <guid
isPermaLink="false">http://www.medimise.com/?p=292</guid> <description><![CDATA[TweetTypes of Skin Lesions As we age it becomes more common to develop skin growths and pigment spots on the skin. They can vary from harmless warts, liver spots or age spots to skin cancer due to years of sun exposure. Among the most common are the red or brown scaly spots, known as actinic keratoses. If left untreated they may become skin cancers that eventually will need to be removed by surgery. If treated early these spots can be removed by freezing with liquid nitrogen, applying a chemotherapy cream or by skin resurfacing. Squamous cell carcinoma is a type of skin cancer that can destroy normal tissue, typically develops on the rim of the ear, the face, the lips or the back of hands, occasionally it spreads to internal organs. If left untreated it can be aggressive. The most common type of skin cancer is a basal cell carcinoma. It normally starts as a small, shiny bump or pinpoint red bleeding area on the head, face, nose, neck or chest. It tends to be more common in older people with fair skin, blond or red hair and blue or green eyes. If left untreated, they can bleed and crust [...]]]></description> <wfw:commentRss>http://www.medimise.com/cancer/types-of-skin-lesions-and-growths/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> </channel> </rss>
